{"id":27968,"date":"2025-12-30T16:12:55","date_gmt":"2025-12-30T23:12:55","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27968"},"modified":"2025-12-30T16:12:57","modified_gmt":"2025-12-30T23:12:57","slug":"ivig-for-major-surgery-associated-secondary-immunosuppression","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/","title":{"rendered":"IgIV para la inmunosupresi\u00f3n secundaria asociada a cirug\u00eda mayor"},"content":{"rendered":"<p>Tras procedimientos quir\u00fargicos mayores, como un trasplante de \u00f3rganos o una cirug\u00eda a coraz\u00f3n abierto, el cuerpo experimenta mucho m\u00e1s de lo que se ve a simple vista. El estr\u00e9s f\u00edsico de los procedimientos puede debilitar el sistema inmunitario, lo que tambi\u00e9n se conoce como inmunosupresi\u00f3n secundaria asociada a cirug\u00eda mayor o inmunosupresi\u00f3n secundaria inducida por cirug\u00eda.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-3c5aab65e58d2e6c1905f59605c56bc0\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u00bfCalifica usted para el copago $0?\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tHable con un especialista para averiguarlo\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>La inmunosupresi\u00f3n secundaria despu\u00e9s de una cirug\u00eda mayor tambi\u00e9n aumenta los riesgos de complicaciones graves como neumon\u00eda, infecci\u00f3n del torrente sangu\u00edneo (sepsis) o retraso en la cicatrizaci\u00f3n de heridas en muchos pacientes.\u00a0<a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\">Inmunoglobulina intravenosa (IVIG)<\/a> A veces se utiliza como terapia complementaria para apoyar el sistema inmunol\u00f3gico durante este per\u00edodo vulnerable.\u00a0<\/p>\n\n\n\n<p>Contin\u00fae leyendo para conocer qu\u00e9 es la inmunosupresi\u00f3n relacionada con la cirug\u00eda, qu\u00e9 muestran estudios recientes, c\u00f3mo puede ayudar la IgIV y qui\u00e9n puede beneficiarse con este tratamiento.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#Major_Surgery-Associated_Secondary_Immunosuppression_Overview\" >Inmunosupresi\u00f3n secundaria asociada a cirug\u00eda mayor: descripci\u00f3n general<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#Clinical_Consequences_of_Surgery-Induced_Immunosuppression\" >Consecuencias cl\u00ednicas de la inmunosupresi\u00f3n inducida por cirug\u00eda<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#IVIG_and_Secondary_Immunosuppression_After_Surgery_What_Research_Says\" >IgIV e inmunosupresi\u00f3n secundaria despu\u00e9s de la cirug\u00eda: qu\u00e9 dicen las investigaciones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#Understanding_the_Role_of_IVIG_in_Surgery-Induced_Immunosuppression\" >Comprensi\u00f3n del papel de la IgIV en la inmunosupresi\u00f3n inducida por cirug\u00eda<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#1_Restores_Antibody_Levels_and_Clears_Pathogens\" >1. Restaura los niveles de anticuerpos y elimina los pat\u00f3genos.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#2_Modulates_Immune_Cell_Function\" >2. Modula la funci\u00f3n de las c\u00e9lulas inmunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#3_Reduces_Risk_of_Post-operative_Infections\" >3. Reduce el riesgo de infecciones postoperatorias<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#4_Has_Potential_Anti-Inflammatory_Effects\" >4. Tiene posibles efectos antiinflamatorios.<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#Who_Might_Be_Considered_for_IVIG\" >\u00bfQui\u00e9n podr\u00eda ser considerado para recibir IgIV?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#Risks_Limitations_and_Cost\" >Riesgos, limitaciones y costos<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#The_Bottom_Line\" >El resultado final<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Major_Surgery-Associated_Secondary_Immunosuppression_Overview\"><\/span><strong>Inmunosupresi\u00f3n secundaria asociada a cirug\u00eda mayor: descripci\u00f3n general<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Importante <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1479666X10001769#:~:text=Conclusion,and%20its%20consequences%20for%20patients.\">inmunosupresi\u00f3n secundaria asociada a la cirug\u00eda<\/a> ocurre como consecuencia de un factor externo (como la cirug\u00eda y el estr\u00e9s f\u00edsico que crea), no por una enfermedad o un defecto inmunol\u00f3gico primario que el paciente ya pueda tener.&nbsp;<\/p>\n\n\n\n<p>Generalmente, cuando una persona se somete a una cirug\u00eda mayor, como una cirug\u00eda card\u00edaca, una cirug\u00eda de \u00f3rganos, una reparaci\u00f3n de un trauma o una operaci\u00f3n abdominal importante, su cuerpo experimenta cambios inmunol\u00f3gicos dr\u00e1sticos.&nbsp;<\/p>\n\n\n\n<p>El sistema inmunol\u00f3gico reacciona en dos etapas: la <a href=\"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/10.1111\/anae.15896\">fase de hiperinflamaci\u00f3n<\/a> y la fase antiinflamatoria compensatoria (CARS).&nbsp;<\/p>\n\n\n\n<p>En la fase de hiperinflamaci\u00f3n, que comienza pocas horas despu\u00e9s de la cirug\u00eda, el cuerpo activa una fuerte respuesta inflamatoria para controlar la lesi\u00f3n tisular. Los niveles de <a href=\"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/10.1111\/anae.15896\">Las mol\u00e9culas inflamatorias (como TNF-\u03b1, IL-1\u03b2 e IL-6) aumentan<\/a>, Las c\u00e9lulas inmunes se apresuran al lugar de la lesi\u00f3n y se produce hinchaz\u00f3n como parte del proceso de curaci\u00f3n.&nbsp;<\/p>\n\n\n\n<p>Tras este pico inicial, el cuerpo entra en la fase CARS para calmar la inflamaci\u00f3n causada por el aumento de citocinas y la mayor actividad inmunitaria. Sin embargo, a veces, esta &quot;respuesta calmante&quot; se vuelve tan intensa que provoca inmunosupresi\u00f3n. Esto provoca:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Actividad reducida de las c\u00e9lulas inmunes (por ejemplo, c\u00e9lulas T, c\u00e9lulas B y c\u00e9lulas asesinas naturales)\u00a0<\/li>\n\n\n\n<li>Niveles reducidos de anticuerpos (IgG e IgM)<\/li>\n\n\n\n<li>Niveles desequilibrados de citocinas protectoras<\/li>\n\n\n\n<li>Deterioro de la funci\u00f3n de los neutr\u00f3filos y macr\u00f3fagos<\/li>\n<\/ul>\n\n\n\n<p>Estos cambios suelen durar desde varios d\u00edas hasta varias semanas.<strong>,<\/strong> dependiendo del tipo de cirug\u00eda y condici\u00f3n del paciente.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Clinical_Consequences_of_Surgery-Induced_Immunosuppression\"><\/span><strong>Consecuencias cl\u00ednicas de la inmunosupresi\u00f3n inducida por cirug\u00eda<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Muchos pacientes postoperatorios, especialmente aquellos de edad avanzada y en estado cr\u00edtico, se vuelven vulnerables a complicaciones graves debido a la baja resistencia inmunitaria (inmunosupresi\u00f3n secundaria). Algunas de las complicaciones cl\u00ednicas reportadas incluyen:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/hypogammaglobulinemia\/\">Hipogammaglobulinemia<\/a> (bajo nivel de anticuerpos circulantes)<\/li>\n\n\n\n<li>Infecciones postoperatorias (como <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5412519\/#:~:text=Postoperative%20pneumonia%20is%20a%20major%20complication%20of,Pneumonia%20developing%2048%E2%80%9372%20hours%20after%20endotracheal%20intubation\">neumon\u00eda<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560533\/#:~:text=Complications%20arising%20from%20surgical%20wound,comorbid%20conditions%20may%20be%20exacerbated.\">infecci\u00f3n de la herida<\/a>, <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0039606023000065#:~:text=1,a%20potentially%20treatable%20postoperative%20complication.\">sepsis o shock s\u00e9ptico<\/a>)<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547669\/\">S\u00edndrome de respuesta inflamatoria sist\u00e9mica grave (SIRS)<\/a><\/li>\n\n\n\n<li>Recuperaci\u00f3n m\u00e1s lenta y estancias m\u00e1s prolongadas en UCI o en el hospital<\/li>\n<\/ul>\n\n\n\n<p>Por ejemplo, una <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022522313008271\">estudiar<\/a> Se descubri\u00f3 que los beb\u00e9s sometidos a cirug\u00eda card\u00edaca con derivaci\u00f3n cardiopulmonar experimentaron una disminuci\u00f3n dr\u00e1stica de sus niveles de IgG (reducidos a menos de la mitad del valor basal en 24 horas). M\u00e1s de la mitad de los ni\u00f1os (aproximadamente 53%) desarrollaron... <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/hypogammaglobulinemia\/\">hipogammaglobulinemia<\/a> (IgG baja). Esto demuestra cu\u00e1nto puede debilitar la cirug\u00eda sus defensas inmunitarias.<\/p>\n\n\n\n<p>De manera similar, una <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5911168\/#:~:text=Stress%20is%20a%20set%20of,the%20acute%20phase%20reaction%20mediators.\">estudio prospectivo<\/a> En un estudio de 60 pacientes sometidos a cirug\u00eda abdominal, se observ\u00f3 que quienes se sometieron a cirug\u00eda de emergencia desarrollaron s\u00edndrome de respuesta inflamatoria sist\u00e9mica (SIRS) despu\u00e9s de la cirug\u00eda. Las puntuaciones m\u00e1s altas de SIRS se asociaron con una recuperaci\u00f3n m\u00e1s lenta y estancias hospitalarias m\u00e1s prolongadas.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-d4712a458b70ffb8892383530a24e4c1\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"IVIG_and_Secondary_Immunosuppression_After_Surgery_What_Research_Says\"><\/span><strong>IgIV e inmunosupresi\u00f3n secundaria despu\u00e9s de la cirug\u00eda: qu\u00e9 dicen las investigaciones<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Actualmente no existen datos s\u00f3lidos y de alta calidad que examinen directamente el uso de IgIV para la inmunosupresi\u00f3n secundaria asociada a cirug\u00eda mayor. Sin embargo, varios estudios relacionados han reportado los efectos prometedores de la IgIV en el manejo de las complicaciones postoperatorias que pueden ser causadas por la inmunosupresi\u00f3n secundaria.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Por ejemplo, una <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10446821\/\">estudio prospectivo, de centro \u00fanico, doble ciego y aleatorizado<\/a> Un estudio inform\u00f3 que cuando se administr\u00f3 una soluci\u00f3n intravenosa enriquecida con inmunoglobulina A e inmunoglobulina M inmediatamente despu\u00e9s de una cirug\u00eda card\u00edaca, redujo significativamente la incidencia de infecciones postoperatorias en los pacientes.<\/p>\n\n\n\n<p>De manera similar, un <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39885983\/\">Estudio retrospectivo basado en UCI<\/a> descubrieron que el uso de IgIV en pacientes s\u00e9pticos en UCI redujo significativamente la mortalidad hospitalaria y mejor\u00f3 los biomarcadores de laboratorio (por ejemplo, PCR, alb\u00famina) con el tiempo.&nbsp;<\/p>\n\n\n\n<p>Adem\u00e1s, una <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37898763\/\">revisi\u00f3n sistem\u00e1tica reciente<\/a> y un metan\u00e1lisis mostr\u00f3 que la IgIV, particularmente la IgIV enriquecida con IgM, es eficaz tanto en la sepsis adulta como en la neonatal y reduce la mortalidad por sepsis.&nbsp;<\/p>\n\n\n\n<p>Estos hallazgos, en conjunto, indican que la IgIV puede ayudar a mitigar las complicaciones posquir\u00fargicas que puede inducir la inmunosupresi\u00f3n. Sin embargo, se requieren m\u00e1s estudios cl\u00ednicos y ensayos exhaustivos para evaluar los beneficios de la IgIV en la inmunosupresi\u00f3n secundaria tras la cirug\u00eda.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Understanding_the_Role_of_IVIG_in_Surgery-Induced_Immunosuppression\"><\/span><strong>Comprensi\u00f3n del papel de la IgIV en la inmunosupresi\u00f3n inducida por cirug\u00eda<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-at-home-2.jpg\" alt=\"Patient receiving IVIG at home while reading a book\" class=\"wp-image-27970\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-at-home-2.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-at-home-2-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-at-home-2-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-at-home-2-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-at-home-2-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-at-home-2-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-at-home-2-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-at-home-2-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Como ya se mencion\u00f3, la IgIV es prometedora en ciertas situaciones posoperatorias, especialmente cuando un paciente presenta una infecci\u00f3n grave (sepsis\/choque s\u00e9ptico) debido a la inmunosupresi\u00f3n. A continuaci\u00f3n, se presentan varias maneras en que la IgIV puede ayudar a reducir la inmunosupresi\u00f3n inducida por la cirug\u00eda.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"1_Restores_Antibody_Levels_and_Clears_Pathogens\"><\/span>1. <strong>Restaura los niveles de anticuerpos y elimina los pat\u00f3genos.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Se ha descubierto que los pacientes con procedimientos complejos como la cirug\u00eda card\u00edaca con <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022522313008271\">La derivaci\u00f3n cardiopulmonar a menudo desarrolla hipogammaglobulinemia.<\/a> (a<strong> <\/strong>ca\u00edda brusca de los niveles de IgG\/IgM debido a p\u00e9rdida de sangre, catabolismo o fuga capilar).&nbsp;<\/p>\n\n\n\n<p>Dado que la IgIV es esencialmente un conjunto concentrado de <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/immunoglobulins-ig\/\">anticuerpos<\/a> De miles de donantes, la administraci\u00f3n de IgIV puede restaurar los niveles de anticuerpos. Estos anticuerpos combaten los pat\u00f3genos que podr\u00edan causar infecciones secundarias posoperatorias.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2_Modulates_Immune_Cell_Function\"><\/span>2. <strong>Modula la funci\u00f3n de las c\u00e9lulas inmunes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La cirug\u00eda mayor da\u00f1a las c\u00e9lulas inmunitarias, como las c\u00e9lulas T, las c\u00e9lulas B y los monocitos, y reduce su capacidad de respuesta a las infecciones. La IgIV contiene anticuerpos que interact\u00faan con las c\u00e9lulas inmunitarias para mejorar su funci\u00f3n.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Impulsar la fagocitosis (c\u00f3mo las c\u00e9lulas inmunes \u201ccomen\u201d las bacterias)<\/li>\n\n\n\n<li>Apoyando las respuestas de las c\u00e9lulas T<\/li>\n\n\n\n<li>Regulaci\u00f3n de las v\u00edas inflamatorias<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"3_Reduces_Risk_of_Post-operative_Infections\"><\/span>3. <strong>Reduce el riesgo de infecciones postoperatorias<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Al restaurar los anticuerpos y apoyar la funci\u00f3n de las c\u00e9lulas inmunes, la IgIV puede reducir la susceptibilidad a infecciones posoperatorias comunes, como neumon\u00eda, infecciones del sitio quir\u00fargico o infecciones del torrente sangu\u00edneo.<\/p>\n\n\n\n<p>Por ejemplo, una <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39201107\/\">estudio retrospectivo<\/a> de los pacientes adultos sometidos a un trasplante ortot\u00f3pico de h\u00edgado (THO) que recibieron una IgIV enriquecida en IgM (en lugar de una formulaci\u00f3n est\u00e1ndar de solo IgG) tuvieron una tasa significativamente menor de nuevas infecciones bacterianas o f\u00fangicas en los primeros 30 d\u00edas despu\u00e9s del trasplante y<strong> <\/strong>Mejor supervivencia a los 90 d\u00edas.<strong>&nbsp;<\/strong><\/p>\n\n\n\n<p>Algunos estudios sugieren que los pacientes que reciben IgIV muestran una normalizaci\u00f3n m\u00e1s r\u00e1pida de los marcadores inflamatorios, lo que indica una mejor respuesta inmune, aunque la evidencia es limitada.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"4_Has_Potential_Anti-Inflammatory_Effects\"><\/span>4. <strong>Tiene posibles efectos antiinflamatorios<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La cirug\u00eda desencadena una respuesta inmunitaria de dos fases: hiperinflamaci\u00f3n (inmediatamente despu\u00e9s de la cirug\u00eda) seguida de inmunosupresi\u00f3n. Esta disminuci\u00f3n repentina de la fuerza inmunitaria tambi\u00e9n aumenta el riesgo de infecci\u00f3n.&nbsp;<\/p>\n\n\n\n<p>IVIG, que tiene <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6560225\/\">propiedades antiinflamatorias<\/a>, puede ayudar a equilibrar la respuesta inmune, prevenir la inflamaci\u00f3n excesiva y apoyar la defensa contra los pat\u00f3genos.<\/p>\n\n\n\n<p>Si bien la IgIV presenta estos beneficios te\u00f3ricos, la evidencia cl\u00ednica actual es limitada. La IgIV suele reservarse para pacientes de alto riesgo, especialmente aquellos con deficiencia documentada de anticuerpos, receptores de trasplantes y pacientes con infecciones graves o riesgo de sepsis posoperatoria.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-aa3922fa6d90bef1c6727ae9ed6aaa24\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_Might_Be_Considered_for_IVIG\"><\/span><strong>\u00bfQui\u00e9n podr\u00eda ser considerado para recibir IgIV?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La IgIV no se utiliza de forma rutinaria en todos los pacientes quir\u00fargicos. Por el contrario, generalmente se reserva para individuos de alto riesgo seleccionados seg\u00fan su estado cl\u00ednico, resultados de laboratorio y riesgo de infecci\u00f3n. Entre los pacientes que podr\u00edan considerarse se incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Receptores de trasplantes de \u00f3rganos s\u00f3lidos o de coraz\u00f3n\/pulm\u00f3n\/h\u00edgado<\/strong> con hipogammaglobulinemia o infecciones recurrentes\/graves<\/li>\n\n\n\n<li><strong>Pacientes postoperatorios con niveles bajos de inmunoglobulina documentados<\/strong> (por ejemplo, IgG baja) y un alto riesgo de infecci\u00f3n grave<\/li>\n\n\n\n<li><strong>Pacientes cr\u00edticos con sepsis o shock s\u00e9ptico<\/strong> en quienes se sospecha disfunci\u00f3n inmunol\u00f3gica o niveles bajos de anticuerpos<\/li>\n\n\n\n<li><strong>Beb\u00e9s u otros pacientes vulnerables<\/strong> despu\u00e9s de procedimientos complejos (como cirug\u00eda card\u00edaca con derivaci\u00f3n cardiopulmonar) que desarrollan una p\u00e9rdida significativa de anticuerpos<\/li>\n<\/ul>\n\n\n\n<p>La decisi\u00f3n de utilizar IgIV siempre es individualizada y la toma el equipo de especialistas tratantes, teniendo en cuenta los posibles beneficios, riesgos y terapias alternativas.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risks_Limitations_and_Cost\"><\/span><strong>Riesgos, limitaciones y costos<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Como cualquier producto derivado de la sangre, la IgIV conlleva riesgos potenciales y no es apropiada para todos. Posible <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/understanding-the-common-side-effects-of-ivig-treatment\/\">efectos secundarios<\/a> incluyen reacciones a la infusi\u00f3n (como dolor de cabeza, fiebre o escalofr\u00edos), sobrecarga de l\u00edquidos y, m\u00e1s raramente, complicaciones graves como lesi\u00f3n renal o co\u00e1gulos de sangre en pacientes que ya est\u00e1n en riesgo.<\/p>\n\n\n\n<p>Adem\u00e1s, la evidencia actual sobre el uso de IgIV espec\u00edficamente en la inmunosupresi\u00f3n secundaria asociada a la cirug\u00eda es limitada y se basa principalmente en estudios peque\u00f1os o heterog\u00e9neos, por lo que a\u00fan se est\u00e1n desarrollando directrices de tratamiento claras. La IgIV tambi\u00e9n es una terapia costosa y podr\u00eda no estar cubierta o aprobada para todas las indicaciones, lo que significa que su uso suele reservarse para pacientes en quienes el beneficio esperado justifica el costo y los posibles riesgos.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_Bottom_Line\"><\/span><strong>El resultado final<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Las cirug\u00edas mayores pueden debilitar temporalmente el sistema inmunitario, lo que provoca inmunosupresi\u00f3n secundaria, lo que aumenta el riesgo de infecciones y retrasa la recuperaci\u00f3n. La IgIV puede ayudar a reforzar la inmunidad, pero los datos sobre su uso espec\u00edfico para la inmunosupresi\u00f3n secundaria asociada a la cirug\u00eda son limitados.&nbsp;<\/p>\n\n\n\n<p>Sin embargo, pocos estudios sugieren un papel potencial de la IgIV en las complicaciones postoperatorias e indican que puede considerarse en pacientes de alto riesgo, como los receptores de trasplantes o aquellos con deficiencias de anticuerpos o shock s\u00e9ptico.<\/p>","protected":false},"excerpt":{"rendered":"<p>Tras procedimientos quir\u00fargicos mayores, como un trasplante de \u00f3rganos o una cirug\u00eda a coraz\u00f3n abierto, el cuerpo experimenta mucho m\u00e1s de lo que se ve a simple vista. El estr\u00e9s f\u00edsico de los procedimientos puede debilitar el sistema inmunitario, lo que tambi\u00e9n se conoce como inmunosupresi\u00f3n secundaria asociada a cirug\u00eda mayor o inmunosupresi\u00f3n secundaria inducida por cirug\u00eda.\u00a0<\/p>","protected":false},"author":26,"featured_media":27969,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[32],"class_list":["post-27968","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-robert-hakim"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG For Major Surgery-Associated Secondary Immunosuppression - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Overview of surgery-induced immunosuppression, postoperative inflammation, infection risk, and evidence for IVIG use in critical and transplant patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG For Major Surgery-Associated Secondary Immunosuppression - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Overview of surgery-induced immunosuppression, postoperative inflammation, infection risk, and evidence for IVIG use in critical and transplant patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-30T23:12:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-30T23:12:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Robert Hakim, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Robert Hakim, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/\"},\"author\":{\"name\":\"Dr. Robert Hakim, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\"},\"headline\":\"IVIG For Major Surgery-Associated Secondary Immunosuppression\",\"datePublished\":\"2025-12-30T23:12:55+00:00\",\"dateModified\":\"2025-12-30T23:12:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/\"},\"wordCount\":1360,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/ivig-1.jpg\",\"keywords\":[\"Dr. Robert Hakim\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/\",\"name\":\"IVIG For Major Surgery-Associated Secondary Immunosuppression - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/ivig-1.jpg\",\"datePublished\":\"2025-12-30T23:12:55+00:00\",\"dateModified\":\"2025-12-30T23:12:57+00:00\",\"description\":\"Overview of surgery-induced immunosuppression, postoperative inflammation, infection risk, and evidence for IVIG use in critical and transplant patients.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/ivig-1.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/ivig-1.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Patient on bed receiving IVIG for major surgery-associated secondary immunosuppression\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-major-surgery-associated-secondary-immunosuppression\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG For Major Surgery-Associated Secondary Immunosuppression\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\",\"name\":\"Dr. Robert Hakim, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"caption\":\"Dr. Robert Hakim, PharmD\"},\"description\":\"Dr. Robert Chad Hakim, PharmD, was born and raised in Northridge, CA. He received his pharmacy degree from the University of Wisconsin-Madison School of Pharmacy. The most rewarding part of his job is taking initiative to advance clinical programs that maximize impact on patient care. He has a board certification in critical care (BCCCP), and his areas of expertise are critical care, drug information, general medicine, and cardiology. In his free time, he enjoys traveling.\u00a0\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/robert-hakim\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IgIV para la inmunosupresi\u00f3n secundaria asociada a cirug\u00eda mayor - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Descripci\u00f3n general de la inmunosupresi\u00f3n inducida por cirug\u00eda, inflamaci\u00f3n posoperatoria, riesgo de infecci\u00f3n y evidencia del uso de IgIV en pacientes cr\u00edticos y trasplantados.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG For Major Surgery-Associated Secondary Immunosuppression - AmeriPharma\u00ae Specialty Care","og_description":"Overview of surgery-induced immunosuppression, postoperative inflammation, infection risk, and evidence for IVIG use in critical and transplant patients.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-12-30T23:12:55+00:00","article_modified_time":"2025-12-30T23:12:57+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg","type":"image\/jpeg"}],"author":"Dr. Robert Hakim, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Robert Hakim, PharmD","Est. reading time":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/"},"author":{"name":"Dr. Robert Hakim, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759"},"headline":"IVIG For Major Surgery-Associated Secondary Immunosuppression","datePublished":"2025-12-30T23:12:55+00:00","dateModified":"2025-12-30T23:12:57+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/"},"wordCount":1360,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg","keywords":["Dr. Robert Hakim"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/","url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/","name":"IgIV para la inmunosupresi\u00f3n secundaria asociada a cirug\u00eda mayor - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg","datePublished":"2025-12-30T23:12:55+00:00","dateModified":"2025-12-30T23:12:57+00:00","description":"Descripci\u00f3n general de la inmunosupresi\u00f3n inducida por cirug\u00eda, inflamaci\u00f3n posoperatoria, riesgo de infecci\u00f3n y evidencia del uso de IgIV en pacientes cr\u00edticos y trasplantados.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg","width":1280,"height":853,"caption":"Patient on bed receiving IVIG for major surgery-associated secondary immunosuppression"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-surgery-associated-secondary-immunosuppression\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"IVIG For Major Surgery-Associated Secondary Immunosuppression"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759","name":"Dr. Robert Hakim, Doctor en Farmacia","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","caption":"Dr. Robert Hakim, PharmD"},"description":"El Dr. Robert Chad Hakim, PharmD, naci\u00f3 y creci\u00f3 en Northridge, California. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Wisconsin-Madison. Lo m\u00e1s gratificante de su trabajo es tomar la iniciativa para impulsar programas cl\u00ednicos que maximicen el impacto en la atenci\u00f3n al paciente. Cuenta con una certificaci\u00f3n del consejo en cuidados cr\u00edticos (BCCCP) y sus \u00e1reas de especializaci\u00f3n son cuidados cr\u00edticos, informaci\u00f3n sobre medicamentos, medicina general y cardiolog\u00eda. En su tiempo libre, disfruta viajando.\u00a0","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"uagb_comment_info":0,"uagb_excerpt":"After major surgical procedures like organ transplantation or open-heart surgery, your body goes through a lot more than what you see on the outside. The physical stress of the procedures can weaken your immune system, which is also known as major surgery-associated secondary immunosuppression or surgery-induced secondary immunosuppression.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/12\/ivig-1.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"After major surgical procedures like organ transplantation or open-heart surgery, your body goes through a lot more than what you see on the outside. The physical stress of the procedures can weaken your immune system, which is also known as major surgery-associated secondary immunosuppression or surgery-induced secondary immunosuppression.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27968"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27968\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27969"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27968"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}